The 20 Hottest Pipeline Drugs to Watch in 2019
Pharm Exec’s 2019 Pipeline Report
FDA Approves DAURISMO™ (glasdegib) for Acute Myeloid Leukemia (AML)
Research Roundup: HIV, the Microbiome and Cancer, and Fruits & Veggies
Verastem Gets FDA Approval for Leukemia Drug, Will Make It Immediately Available to Patients
Genmab is partnering with the German company Immatics to develop immunotherapies directed against three cancer targets. Genmab has offered Immatics, based in Tuebingen, Germany, an upfront payment of $54M … Continue Reading Collaboration Worth Over €1Bn Could Give Rise to New Cancer Immunotherapies
Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need of better therapies to treat these cancers – which are … Continue Reading It’s Blood Cancer Day, how is Biotech fixing it?